<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="pmc">eid</journal-id>
      <journal-title>Emerging Infectious Diseases</journal-title>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">10081684</article-id>
      <article-id pub-id-type="pmc">2627682</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation.</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Meis</surname>
            <given-names>J. F.</given-names>
          </name>
          <email>j.meis@mmb.azn.nl</email>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ruhnke</surname>
            <given-names>M.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>De Pauw</surname>
            <given-names>B. E.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Odds</surname>
            <given-names>F. C.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Siegert</surname>
            <given-names>W.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Verweij</surname>
            <given-names>P. E.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff>University Hospital Sint Radboud, Nijmegen, The Netherlands.</aff>
      <pub-date pub-type="ppub">
        <season>Jan-Feb</season>
        <year>1999</year>
      </pub-date>
      <volume>5</volume>
      <issue>1</issue>
      <fpage>150</fpage>
      <lpage>153</lpage>
      <abstract>
        <p>The recently described species Candida dubliniensis has been recovered primarily from superficial oral candidiasis in HIV-infected patients. No clinically documented invasive infections were reported until now in this patient group or in other immunocompromised patients. We report three cases of candidemia due to this newly emerging Candida species in HIV-negative patients with chemotherapy-induced immunosuppression and bone marrow transplantation.</p>
      </abstract>
    </article-meta>
  </front>
</article>
</pmc-articleset>
